Literature DB >> 8664718

Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit.

C Harding1, W F Knox, E B Faragher, A Baildam, N J Bundred.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8664718      PMCID： PMC2351395          DOI： 10.1136/bmj.312.7047.1646

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Update on hormone replacement therapy.

Authors:  R D Gambrell
Journal:  Am Fam Physician       Date:  1992-11       Impact factor: 3.292

2.  Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy.

Authors:  K Hunt; M Vessey; K McPherson; M Coleman
Journal:  Br J Obstet Gynaecol       Date:  1987-07

3.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.

Authors:  G A Colditz; S E Hankinson; D J Hunter; W C Willett; J E Manson; M J Stampfer; C Hennekens; B Rosner; F E Speizer
Journal:  N Engl J Med       Date:  1995-06-15       Impact factor: 91.245

4.  Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.

Authors:  L Bergkvist; H O Adami; I Persson; R Bergström; U B Krusemo
Journal:  Am J Epidemiol       Date:  1989-08       Impact factor: 4.897

5.  A prognostic index in primary breast cancer.

Authors:  J L Haybittle; R W Blamey; C W Elston; J Johnson; P J Doyle; F C Campbell; R I Nicholson; K Griffiths
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640
  5 in total
  7 in total

1.  Effect of hormone replacement therapy on the pathological stage of breast cancer: population based, cross sectional study.

Authors:  S Stallard; J C Litherland; C M Cordiner; H M Dobson; W D George; E A Mallon; D Hole
Journal:  BMJ       Date:  2000-02-05

2.  Breast tumor characteristics in hormone replacement therapy users.

Authors:  Jasmina-Ziva Cerne; Snjezana Frkovic-Grazio; Ksenija Gersak
Journal:  Pathol Oncol Res       Date:  2011-06-16       Impact factor: 3.201

3.  Prediagnostic use of hormone therapy and mortality after breast cancer.

Authors:  Polly A Newcomb; Kathleen M Egan; Amy Trentham-Dietz; Linda Titus-Ernstoff; John A Baron; John M Hampton; Meir J Stampfer; Walter C Willett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04-01       Impact factor: 4.254

4.  Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study.

Authors:  Lena U Rosenberg; Fredrik Granath; Paul W Dickman; Kristjana Einarsdóttir; Sara Wedrén; Ingemar Persson; Per Hall
Journal:  Breast Cancer Res       Date:  2008-09-19       Impact factor: 6.466

5.  Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients.

Authors:  H Jernström; J Frenander; M Fernö; H Olsson
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

6.  Epithelial proliferation and hormone receptor status in the normal post-menopausal breast and the effects of hormone replacement therapy.

Authors:  D F Hargreaves; F Knox; R Swindell; C S Potten; N J Bundred
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

7.  Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy.

Authors:  C Stahlberg; A T Pedersen; Z J Andersen; N Keiding; Y A Hundrup; E B Obel; S Møller; F Rank; B Ottesen; E Lynge
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.